총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Arrowhead Pharmaceuticals, Inc. (ARWR), 포함 13 건 매수 및 33 건 매도. 내부자 매수 총액은 $963.33K 내부자 매도 총액은 $12.5M.
최근 활동이 있는 주요 내부자에는 Hamilton James C, O'brien Patrick, Apel Daniel Joseph. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — ARWR
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2026-03-05 |
Hamilton James C |
Chief Medical Officer |
정보 매도 |
10,000 |
$64.19 |
$641.9K |
236,958 |
| 2026-01-06 |
O'brien Patrick |
COO |
증여 (지급) |
440 |
- |
- |
472,408 |
| 2026-01-06 |
Hamilton James C |
Chief Medical Officer |
RSU 부여 |
75,000 |
- |
- |
246,958 |
| 2026-01-06 |
Apel Daniel Joseph |
Chief Financial Officer |
RSU 부여 |
75,000 |
- |
- |
176,200 |
| 2026-01-05 |
O'brien Patrick |
COO |
정보 매도 |
46 |
$68.00 |
$3.13K |
474,908 |
| 2026-01-05 |
Hamilton James C |
Chief Medical Officer |
정보 매도 |
309 |
$68.00 |
$21.01K |
171,958 |
| 2026-01-02 |
Anzalone Christopher Richard |
Chief Executive Officer |
정보 매도 |
5,771 |
$66.39 |
$383.14K |
3,792,739 |
| 2025-12-31 |
O'brien Patrick |
COO |
증여 (지급) |
560 |
- |
- |
524,401 |
| 2025-12-29 |
Anzalone Christopher Richard |
Chief Executive Officer |
옵션 행사 (매도) |
16,545 |
$6.15 |
$101.75K |
- |
| 2025-12-26 |
Ferrari Mauro |
Director |
정보 매도 |
7,530 |
$70.00 |
$527.1K |
69,053 |
| 2025-12-22 |
Anzalone Christopher Richard |
Chief Executive Officer |
정보 매도 |
2,574 |
$68.85 |
$177.22K |
3,805,926 |
| 2025-12-19 |
Olukotun Adeoye Y |
Director |
정보 매도 |
827 |
$68.48 |
$56.63K |
33,600 |
| 2025-12-19 |
Anzalone Christopher Richard |
Chief Executive Officer |
정보 매도 |
1,319 |
$68.48 |
$90.33K |
3,818,512 |
| 2025-12-19 |
Waddill William D. |
Director |
정보 매도 |
500 |
$68.53 |
$34.27K |
56,563 |
| 2025-12-19 |
Vakiener Victoria |
Director |
정보 매도 |
1,960 |
$68.39 |
$134.04K |
35,723 |
| 2025-12-17 |
Anzalone Christopher Richard |
Chief Executive Officer |
정보 매도 |
1,981 |
$66.30 |
$131.34K |
3,831,957 |
| 2025-12-16 |
Anzalone Christopher Richard |
Chief Executive Officer |
정보 매도 |
3,221 |
$67.87 |
$218.61K |
3,916,957 |
| 2025-12-16 |
Ingram Douglas S |
Director |
RSU 부여 |
7,819 |
- |
- |
46,215 |
| 2025-12-16 |
Olukotun Adeoye Y |
Director |
RSU 부여 |
7,819 |
- |
- |
43,600 |
| 2025-12-16 |
Perry Michael S |
Director |
RSU 부여 |
7,819 |
- |
- |
123,059 |
| 2025-12-16 |
Ferrari Mauro |
Director |
RSU 부여 |
7,819 |
- |
- |
76,583 |
| 2025-12-16 |
Waddill William D. |
Director |
RSU 부여 |
7,819 |
- |
- |
64,930 |
| 2025-12-16 |
Lu Hongbo |
Director |
RSU 부여 |
7,819 |
- |
- |
54,982 |
| 2025-12-16 |
Vakiener Victoria |
Director |
RSU 부여 |
7,819 |
- |
- |
45,763 |
| 2025-12-15 |
Anzalone Christopher Richard |
Chief Executive Officer |
정보 매도 |
8,147 |
$69.96 |
$569.96K |
3,971,255 |
| 2025-12-12 |
Anzalone Christopher Richard |
Chief Executive Officer |
RSU 부여 |
180,000 |
- |
- |
4,101,255 |
| 2025-12-05 |
Perry Michael S |
Director |
정보 매도 |
16,250 |
$61.03 |
$991.74K |
115,240 |
| 2025-11-28 |
Ferrari Mauro |
Director |
정보 매도 |
8,750 |
$56.39 |
$493.41K |
68,764 |
| 2025-10-01 |
Hamilton James C |
Chief Medical Officer |
정보 매도 |
20,000 |
$35.00 |
$700K |
212,122 |
| 2025-09-12 |
Hamilton James C |
Chief Medical Officer |
정보 매도 |
15,000 |
$30.00 |
$450K |
232,122 |
| 2025-09-02 |
Hamilton James C |
Chief Medical Officer |
정보 매도 |
15,000 |
$25.00 |
$375K |
247,122 |
| 2025-08-15 |
Hamilton James C |
Chief Medical Officer |
정보 매도 |
9,389 |
$20.00 |
$187.78K |
262,122 |
| 2025-08-13 |
Hamilton James C |
Chief Medical Officer |
정보 매도 |
611 |
$20.00 |
$12.22K |
271,511 |
| 2025-04-15 |
Apel Daniel Joseph |
Chief Financial Officer |
알 수 없음 |
- |
- |
- |
101,200 |
| 2025-04-11 |
Anzalone Christopher Richard |
Chief Executive Officer |
정보 매도 |
50,800 |
$11.49 |
$583.69K |
3,921,255 |
| 2025-04-10 |
Anzalone Christopher Richard |
Chief Executive Officer |
정보 매도 |
50,000 |
$10.87 |
$543.5K |
3,972,055 |
| 2025-04-09 |
Anzalone Christopher Richard |
Chief Executive Officer |
정보 매도 |
1,617 |
$11.76 |
$19.02K |
4,022,055 |
| 2025-03-13 |
Anzalone Christopher Richard |
Chief Executive Officer |
정보 매도 |
51,425 |
$15.07 |
$774.97K |
4,062,377 |
| 2025-03-04 |
Anzalone Christopher Richard |
Chief Executive Officer |
정보 매도 |
133,333 |
$17.02 |
$2.27M |
3,773,802 |
| 2025-03-03 |
Anzalone Christopher Richard |
Chief Executive Officer |
옵션 행사 (매도) |
133,333 |
$7.75 |
$1.03M |
51,726 |
| 2025-02-07 |
Anzalone Christopher Richard |
Chief Executive Officer |
RSU 부여 |
9,550 |
$20.10 |
$191.96K |
3,773,802 |
| 2025-02-06 |
Ingram Douglas S |
Director |
알 수 없음 |
- |
- |
- |
- |
| 2025-02-06 |
Ingram Douglas S |
Director |
RSU 부여 |
38,396 |
$20.09 |
$771.38K |
38,396 |
| 2025-01-23 |
Olukotun Adeoye Y |
Director |
정보 매도 |
959 |
$21.00 |
$20.14K |
35,781 |
| 2025-01-07 |
Myszkowski Kenneth Allen |
Chief Financial Officer |
정보 매도 |
10,000 |
$19.69 |
$196.9K |
455,433 |
| 2025-01-07 |
O'brien Patrick |
COO and General Counsel |
정보 매도 |
8,000 |
$19.69 |
$157.52K |
527,201 |
| 2025-01-06 |
Myszkowski Kenneth Allen |
Chief Financial Officer |
정보 매도 |
9,402 |
$20.10 |
$188.98K |
473,433 |
| 2025-01-06 |
O'brien Patrick |
COO and General Counsel |
정보 매도 |
9,526 |
$20.10 |
$191.47K |
535,201 |
| 2025-01-06 |
Hamilton James C |
Chief Discovery/trans Medicine |
정보 매도 |
10,971 |
$20.11 |
$220.63K |
272,122 |
| 2025-01-04 |
Myszkowski Kenneth Allen |
Chief Financial Officer |
RSU 부여 |
100,000 |
- |
- |
500,600 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
